Direct comparison
IRB vs. IBC: What's the Difference?
IRB reviews human-subjects risk under the Common Rule; IBC reviews rDNA biosafety under NIH Guidelines. Compared side by side, plus when a study needs both.
Ask about IRB vs. IBC: What's the Difference?
Answers are drawn from this comparison and the rest of the CASRAI corpus, with a link to every source.
Answers are AI-generated from CASRAI’s own published pages and can be wrong, so check the linked sources before relying on one; your question is logged without personal data — never sold, never used to train a third-party model — to show us what CASRAI is missing, so please do not type personal or confidential details. How we use this
How do IRB, IBC compare side by side?
The table below compares IRB, IBC across 7 procurement-relevant dimensions, from what it protects through institution-wide trigger.
Side-by-side comparison
| Dimension | IRB | IBC |
|---|---|---|
| What it protects | Rights and welfare of human research subjects | Lab workers, community, and environment from biohazards |
| Regulatory basis | Common Rule (45 CFR 46); 21 CFR Part 56 for FDA-regulated research | NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules |
| Administering federal office | HHS Office for Human Research Protections (OHRP); FDA for regulated products | NIH Office of Science Policy (OSP) |
| What triggers review | Research (45 CFR 46.102(l)) involving a human subject (45 CFR 46.102(e)) — both conditions required | Use of recombinant/synthetic nucleic acid molecules; most institutions also cover other biohazards by local policy |
| Minimum composition | Majority present at convened meeting, including at least one non-scientist member | At least 5 members with rDNA/containment expertise, including at least 2 unaffiliated community representatives |
| What approval authorizes | Enrollment of human subjects under an approved protocol and consent process | Specific biosafety-level (BSL) procedures under an approved risk-category review |
| Institution-wide trigger | Registration and FWA required per institution operating an IRB for covered research | Once any NIH funding applies to rDNA research, Guidelines apply institution-wide to ALL rDNA work regardless of individual project funding |
Common questions
Common questions about IRB vs IBC
Can the same study need only one of the two committees?
+
Yes. Most studies trigger only one — a survey study needs only IRB review, a non-human bench rDNA experiment needs only IBC review. Overlap arises only when a protocol independently meets both committees' triggers.
Does IBC review require the specific project to be NIH-funded?
+
No. Once an institution receives any NIH funding for recombinant/synthetic nucleic acid molecule research, the NIH Guidelines and IBC review apply institution-wide to all such research, regardless of that project's own funding source.
Which committee assigns the biosafety level?
+
The IBC, through risk-category review of the specific agent, procedure, and volume — not the IRB, even on studies that also require IRB approval.
